Happy Wednesday, OPN!
We are proud to announce that Accenture has just expanded the Accenture Life Sciences Cloud for Research and Development (R&D) powered by Oracle with the addition of enhanced clinical data management capabilities enabling life sciences companies to generate high-quality and reliable data from clinical trials to reduce the time and cost needed to take drugs from development to market.
This latest version of the Accenture Life Sciences Cloud for R&D offers the Oracle Health Sciences Data Management Workbench (DMW), which includes prebuilt integrations to the Oracle Health Sciences InForm, an electronic data capture (EDC) solution to create an end-to-end clinical data collection and management platform.
With the addition of the Oracle Health Sciences DMW, the Accenture Life Sciences Cloud for R&D automates the time-consuming manual processes required to load, transform and clean trial data. Trial sponsors and contract research organizations can now increase the speed and accuracy of data collection, integration and analysis; achieve greater efficiency of clinical workflow and query management; and accelerate stakeholders’ access to data across the trial lifecycle from source to submission.
“Being able to take advantage of new technologies for clinical data management in combination with Oracle InForm is a key factor to helping our clients bring life-improving medicines to patients faster,” said managing director of Accelerated R&D Services, Accenture Life Sciences. “We are proud to launch the latest version of Accenture Life Sciences Cloud for R&D, which harnesses the highly differentiated capabilities of a pre-integrated end-to-end clinical R&D platform based on leading technology from Oracle.”
As previously announced in October, the Life Sciences Cloud Coalition is a ground-breaking initiative, in parallel with the Accenture Life Sciences Cloud for R&D platform, to build an assembly of like-minded leaders, collaborating for a healthier industry in non-competitive areas. The focus of the coalition is on driving innovation in the Accenture Life Sciences Cloud to digitally enable the R&D function, speed the drug development process while improving quality and cost for the industry. Members of the Life Sciences Cloud Coalition include Oracle, Eisai, Pfizer, Merck and other leading pharmaceutical companies.
Oracle continues to
innovate in a range of industries with our partners. This announcement is a
great example of how being a cloud-ready member of OPN, can extend your reach
of providing industry-leading cloud solutions and services to customers.